Business Wire

Antibe Reports 2023 Year-End Results and Business Highlights

- Completed transition to otenaproxesul’s new formulation; tablet manufacturing underway - PK/PD study results expected in calendar Q4 2023 with Phase II initiation in Q1 2024 - Ended year with $38.9 million in cash and equivalentsTORONTO--(BUSINESS WI

More

Nomic Bio Appoints Byron Hewett to its Board of Directors

MONTREAL--(BUSINESS WIRE)--#proteinprofiling--Nomic Bio, a pioneering protein profiling company, today announced the appointment of Byron Hewett to its board of directors. Hewett brings invaluable operational and strategic expertise to guide Nomic Bio thr

More